ACE and diabetic kidney disease: Clinical experiments revealed that renin-angiotensin-aldosterone system (RAS) inhibitors, especially angiotensin-converting-enzyme inhibitor (ACE-I) and angiotensin II receptor blocker (ARB), was found to be effective in treating DKD.